|
Pluristem Therapeutics
PSTI
|
$ 1.03 |
-1.9 % |
$ 33.3 M |
Nasdaq Global Select Market |
Israel |
|
Sorrento Therapeutics
SRNE
|
$ 0.27 |
-29.58 % |
$ 126 M |
Nasdaq Global Select Market |
USA |
|
Eyenovia
EYEN
|
$ 0.99 |
-2.34 % |
$ 40.6 M |
Nasdaq Capital Market |
USA |
|
Graybug Vision
GRAY
|
$ 0.44 |
-11.23 % |
$ 9.65 M |
Nasdaq Global Market |
USA |
|
Vallon Pharmaceuticals
VLON
|
$ 0.43 |
-6.47 % |
$ 5.76 M |
Nasdaq Global Select Market |
USA |
|
Caladrius Biosciences
CLBS
|
$ 0.43 |
-16.75 % |
$ 25.8 M |
Nasdaq Capital Market |
USA |
|
ContraFect Corporation
CFRX
|
$ 1.47 |
-5.16 % |
$ 5.39 M |
Nasdaq Capital Market |
USA |
|
Orchard Therapeutics plc
ORTX
|
$ 4.93 |
1.02 % |
$ 90.8 M |
Nasdaq Global Select Market |
Britain |
|
Enlivex Therapeutics Ltd.
ENLV
|
$ 3.86 |
-1.28 % |
$ 71.1 M |
Nasdaq Capital Market |
Israel |
|
Heat Biologics, Inc.
HTBX
|
$ 3.93 |
-5.76 % |
$ 99.8 M |
Nasdaq Capital Market |
USA |
|
La Jolla Pharmaceutical Company
LJPC
|
$ 6.2 |
- |
$ 154 M |
Nasdaq Capital Market |
USA |
|
Zymeworks
ZYME
|
$ 6.42 |
- |
$ 404 M |
NYSE |
Canada |
|
Eli Lilly and Company
LLY
|
$ 778.18 |
0.42 % |
$ 701 B |
NYSE,SPB |
USA |
|
Checkmate Pharmaceuticals
CMPI
|
$ 10.5 |
- |
$ 231 M |
Nasdaq Global Market |
USA |
|
CASI Pharmaceuticals
CASI
|
$ 3.0 |
- |
$ 408 M |
Nasdaq Capital Market |
USA |
|
Kadmon Holdings, Inc.
KDMN
|
$ 9.5 |
- |
$ 1.7 B |
Nasdaq Global Select Market |
USA |
|
BioDelivery Sciences International
BDSI
|
$ 2.58 |
-4.8 % |
$ 255 M |
Nasdaq Global Select Market |
USA |
|
Zosano Pharma Corporation
ZSAN
|
$ 0.56 |
7.23 % |
$ 2.72 M |
Nasdaq Global Select Market |
USA |
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
$ 4.37 |
-1.58 % |
$ 28.1 M |
Nasdaq Global Market |
China |